| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |